Back to Search
SCOTT LIPPMAN, M.D.
M.D.
Medical Oncology Physician
NPI: 1780780874Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
H4987(TX)
Research & Publications (20)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
PMID 19066370·JAMA·2009
3-trial
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
PMID 19318668·Chest·2009
8-other
Cancer prevention research: back to the future.
PMID 19491288·Cancer Prev Res (Phila)·2009
7-preclinical
Cancer prevention: from 1727 to milestones of the past 100 years.
PMID 19491253·Cancer Res·2009
6-review
Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
PMID 19059972·Chest·2008
8-other
The convergent development of molecular-targeted drugs for cancer treatment and prevention.
PMID 17634526·Clin Cancer Res·2007
6-review
Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
PMID 16540634·Cancer Res·2006
6-review
Fenretinide activity in retinoid-resistant oral leukoplakia.
PMID 16707609·Clin Cancer Res·2006
3-trial
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
PMID 15657339·J Natl Cancer Inst·2005
8-other
Oral cancer prevention and the evolution of molecular-targeted drug development.
PMID 15637397·J Clin Oncol·2005
6-review
Cancer prevention and the American Society of Clinical Oncology.
PMID 15353541·J Clin Oncol·2004
8-other
Cancer prevention by delay. Commentary re: J. A. O'Shaughnessy et al., Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development. Clin. Cancer Res., 8: 314-346, 2002.
PMID 11839646·Clin Cancer Res·2002
7-preclinical
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
PMID 11309437·J Natl Cancer Inst·2001
3-trial
Protease inhibitors in oral carcinogenesis and chemoprevention.
PMID 11156207·Clin Cancer Res·2000
6-review
Advances in the development of retinoids as chemopreventive agents.
PMID 10721933·J Nutr·2000
6-review
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
PMID 19584075·Cancer Prev Res (Phila)·2009
8-other
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
PMID 19571599·Oncology·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1780780874
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile